Reduced Regional and Global Cerebral Blood Flow During Fenoldopam-Induced Hypotension in Volunteers
暂无分享,去创建一个
F H Fahey | B A Harkness | R. Prielipp | R. James | J. R. Tobin | F. Fahey | R C Prielipp | D. Stump | B. Harkness | L. Groban | M H Wall | L Groban | J R Tobin | D A Stump | R L James | M A Cannon | J Bennett | J Butterworth | J. Bennett | J. Butterworth | M. Wall | Mark A. Cannon
[1] K. Lawson,et al. Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats. , 1987, Clinical and experimental hypertension. Part A, Theory and practice.
[2] S. Gelman,et al. Transcranial Doppler and rCBF compared in carotid endarterectomy. , 1986, Stroke.
[3] H Iida,et al. Mechanisms of Dexmedetomidine-Induced Cerebrovascular Effects in Canine In Vivo Experiments , 1995, Anesthesia and analgesia.
[4] R. P. Wray. CRYOPROBE LEAKAGE OF NITROUS OXIDE INTO OPERATING ROOM AIR , 1979 .
[5] R. Patterson,et al. The Minnesota impedance cardiograph- theory and applications. , 1974, Biomedical engineering.
[6] C. Iadecola. Neurogenic control of the cerebral microcirculation: is dopamine minding the store? , 1998, Nature Neuroscience.
[7] P. Patel,et al. The cerebral pressure-flow relationship during 1.0 MAC isoflurane anesthesia in the rabbit: the effect of different vasopressors. , 1990, Anesthesiology.
[8] M. L. Marsh,et al. Changes in neurologic status and intracranial pressure associated with sodium nitroprusside administration. , 1979, Anesthesiology.
[9] W. K. Luk,et al. Adaptive, segmented attenuation correction for whole-body PET imaging , 1996 .
[10] K. Minneman. Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. , 1988, Pharmacological reviews.
[11] J. Kirsch,et al. α2-Adrenergic agonist effects on normocapnic and hypercapnic cerebral blood flow in the dog are anesthetic dependent , 1994 .
[12] Mental Disease,et al. Brain imaging and brain function , 1985 .
[13] R. Weinshilboum,et al. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.
[14] M. Zornow,et al. Dexmedetomidine, an α2‐Adrenergic Agonist, Decreases Cerebral Blood Flow in the Isoflurane‐Anesthetized Dog , 1990, Anesthesia and analgesia.
[15] N. Toda. Alpha adrenergic receptor subtypes in human, monkey and dog cerebral arteries. , 1983, The Journal of pharmacology and experimental therapeutics.
[16] K. Herholz. Signal sources in PET. , 1997, Advances in experimental medicine and biology.
[17] Yuko Sato,et al. Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain , 1992, Neuroscience Research.
[18] B. McGrath,et al. Beneficial effects of fenoldopam on systemic and regional hemodynamics in rabbits with congestive heart failure. , 1988, Journal of cardiovascular pharmacology.
[19] W. Frishman,et al. Fenoldopam: A New Dopamine Agonist for the Treatment of Hypertensive Urgencies and Emergencies , 1998, Journal of clinical pharmacology.
[20] D C Jeutter,et al. Determination of cardiac output using ensemble-averaged impedance cardiograms. , 1985, Journal of applied physiology.
[21] J. Kirsch,et al. α2-ADRENERGIC AGONIST EFFECTS ON NORMOCAPNIC AND HYPERCAPNIC CEREBRAL BLOOD FLOW IN THE DOG ARE ANESTHETIC-DEPENDENT , 1994 .
[22] R A Koeppe,et al. Performance Comparison of Parameter Estimation Techniques for the Quantitation of Local Cerebral Blood Flow by Dynamic Positron Computed Tomography , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] Ulrich Dirnagl,et al. Optical Imaging of Brain Function and Metabolism 2 , 1997, Advances in Experimental Medicine and Biology.
[24] S. Garwood,et al. Perioperative renal preservation: Dopexamine and fenoldopam— New agents to augment renal performance , 1998 .
[25] S. Sudikoff,et al. Techniques for measuring cerebral blood flow in children. , 1998, Current opinion in pediatrics.
[26] R. Koehler,et al. Intraventricular Dexmedetomidine Decreases Cerebral Blood Flow During Normoxia and Hypoxia in Dogs , 1997, Anesthesia and analgesia.
[27] R. Lewis,et al. Guidelines for clinical investigator involvement in industry-sponsored clinical trials. SAEM Research Committee. , 1995, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[28] P. Goldman-Rakic,et al. Dopaminergic regulation of cerebral cortical microcirculation , 1998, Nature Neuroscience.
[29] T. Sloan,et al. Neurologic monitoring. , 1988, Critical care clinics.
[30] B. Clyde,et al. The relationship of blood velocity as measured by transcranial doppler ultrasonography to cerebral blood flow as determined by stable xenon computed tomographic studies after aneurysmal subarachnoid hemorrhage. , 1996, Neurosurgery.
[31] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[32] M. Raichle. Positron Emission Tomography with Oxygen-15 Radiopharmaceuticals , 1986 .
[33] C. Grant,et al. A comparison of the effects of norepinephrine, epinephrine, and dopamine on cerebral blood flow and oxygen utilisation. , 1998, Acta neurochirurgica. Supplement.
[34] F. Amenta,et al. Autoradiographic localization of vascular dopamine receptors. , 1990, American journal of hypertension.
[35] B. K. Hartman,et al. Central noradrenergic regulation of cerebral blood flow and vascular permeability. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[36] E. Panacek,et al. Randomized, Prospective Trial of Fenoldopam vs Sodium Nitroprusside in the Treatment of Acute Severe Hypertension , 1995 .
[37] S. Oparil,et al. Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises. , 1999, American journal of hypertension.